We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medicare would pay for investigational clinical services for beneficiaries participating in clinical trials under a new proposal by the Centers for Medicare & Medicaid Services (CMS).
Amgen plans to announce results from an Aranesp small-cell lung cancer clinical trial when the firm reports first-quarter earnings April 23, the company said.
GlaxoSmithKline (GSK) and Adolor stopped development of their bowel-disorder drug and withdrew an application because of increased risk of heart attacks, benign and malignant tumors and bone fractures, the companies said.
Individual adverse events in clinical trials are not necessarily the same thing as unanticipated problems and may not have to be reported as such to the institutional review board (IRBs), according to new draft guidance from the FDA.
Results from a recent study show that anal cytology screening can predict anal dysplasia — the precursor to anal cancer — with an accuracy of roughly 96 percent.
A new analysis of previously conducted studies showed no increase in coronary heart disease for women in their 50s who take hormone therapies close the start of menopause, according to an article in The Journal of the American Medical Association (JAMA).
Percutaneous coronary intervention (PCI) — often involving stents — coupled with drugs is no better at reducing major cardiovascular events than drugs alone, according to a new study.
Abbott Laboratories has “the best stent,” RBC Capital Markets analysts said after data released last week at the American College of Cardiology’s 56th Annual Scientific Session indicate Abbott’s Xience stent is superior to Boston Scientific’s Taxus stent.
Antidepressants are no more effective than placebo for depressed people with bipolar disorder who are taking a mood stabilizer, according to a study in the New England Journal of Medicine.